Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2.

Authors

null

Wassim Abida

Memorial Sloan Kettering Cancer Center, New York, NY

Wassim Abida , Alan Haruo Bryce , Nicholas J. Vogelzang , Robert J. Amato , Ivor John Percent , Jeremy David Shapiro , Raymond S. McDermott , Arif Hussain , Akash Patnaik , Daniel Peter Petrylak , Charles J. Ryan , Thomas S. Stanton , Jingsong Zhang , Andrea Loehr , Andrew Simmons , Darrin Despain , Anthony A. Golsorkhi , Simon Paul Watkins , Howard I. Scher , Simon Chowdhury

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02952534

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5031)

DOI

10.1200/JCO.2019.37.15_suppl.5031

Abstract #

5031

Poster Bd #

143

Abstract Disclosures

Similar Posters

First Author: Fadi Taza

First Author: Heidi Fettke

First Author: Benedito A. Carneiro